Statistics

Total Visits

Views
Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).54

Select a period of time:

Number of views in the range

Views
Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).12

Views

Views
June 20252
July 20258
August 20250
September 20250
October 20251
November 20251
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil6
United States3
Hong Kong2
Ecuador1
 

Top cities views

Views
Hong Kong2
Aparecida de Goiânia1
Aurora1
Chicago1
Itaquaquecetuba1
Mesquite1
Nova Iguaçu1
Orlândia1
Porto Alegre1
Quito1